tiprankstipranks
ProMIS Neurosciences (PMN)
NASDAQ:PMN
Holding PMN?
Track your performance easily

ProMIS Neurosciences (PMN) Income Statement

42 Followers

ProMIS Neurosciences Income Statement

Last quarter (Q2 2024), ProMIS Neurosciences's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, ProMIS Neurosciences's net income was C$-2.62M. See ProMIS Neurosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
---C$ 8.14KC$ 1.23K
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
C$ 12.57MC$ 14.09MC$ 23.20MC$ 8.26MC$ 4.44M
Operating Income
C$ -12.57MC$ -14.09MC$ -23.20MC$ -8.25MC$ -4.44M
Net Non Operating Interest Income Expense
C$ -228.98KC$ -201.39KC$ -282.06KC$ 410.29KC$ -174.00
Other Income Expense
C$ -598.25KC$ -1.08MC$ -5.42MC$ -577.83K-
Pretax Income
C$ -12.20MC$ -13.21MC$ -18.06MC$ -9.24MC$ -4.44M
Tax Provision
-----
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
C$ -12.20MC$ -13.21MC$ -18.06MC$ -9.79MC$ -4.44M
Basic EPS
C$ -0.69C$ -1.07C$ -2.41C$ -108.00-
Diluted EPS
C$ -0.69C$ -1.07C$ -2.41C$ -108.00-
Basic Average Shares
C$ 71.32MC$ 12.29MC$ 7.50MC$ 96.43K-
Diluted Average Shares
C$ 71.32MC$ 12.29MC$ 7.50MC$ 96.43K-
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
C$ 12.57MC$ 14.09MC$ 23.20MC$ -8.26MC$ -4.44M
Net Income From Continuing And Discontinued Operation
C$ -12.20MC$ -13.21MC$ -18.06MC$ -9.79MC$ -4.44M
Normalized Income
C$ -10.56MC$ -9.71MC$ -13.28MC$ -6.85MC$ -3.26M
Interest Expense
-----
EBIT
C$ -11.97MC$ -13.01MC$ -17.78MC$ -9.37MC$ -4.44M
EBITDA
C$ -11.95MC$ -12.99MC$ -17.53MC$ -9.33MC$ -4.43M
Currency in CAD

ProMIS Neurosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis